Buy this ASX 200 healthcare share for a 25% return: broker

There could be big returns ahead for shareholders of this healthcare company.

| More on:
Two healthcare workers, a male doctor in the background with a woman in scrubs in the foreground,, smile towards the camera against a plain backdrop.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're looking for exposure to the healthcare sector, then Ramsay Health Care Ltd (ASX: RHC) could be the way to do it.

That's the view of analysts at Morgans, which see major upside ahead for this ASX 200 healthcare share.

What is the broker saying about this ASX 200 healthcare share?

In response to a recent trading update, the team at Morgans has retained its add rating with a slightly trimmed $75.57 price target.

Based on the current Ramsay share price of $60.58, this implies potential upside of 25% for this ASX 200 healthcare share over the next 12 months.

In addition, the broker is forecasting a 2.2% dividend yield over the next 12 months, boosting the total potential return on offer with its shares even further.

What did it say?

While the broker wasn't blown away by Ramsay Health Care's trading update, it was pleased with underlying trends. It explained:

A nine-month FY23 trading update highlighted improving volumes across all regions on increased surgical activity, although margins and profit lagged. While COVID-related headwinds are subsiding, labour shortages and inflationary pressures remain, dampening a full recovery in underlying profitability.

The good news is that Morgans expects these headwinds to ease in time and for its profits to rebound. It adds:

While the operating environment remains unpredictable and dynamic, with doctor/patient behaviour, inflation and workforce issues all defining the earnings profile, higher activity and improving (albeit slowly) productivity are suggestive of growing momentum.

All in all, the sum of the above is that the broker believes that this makes Ramsay an ASX 200 health care share to buy right now for patient investors.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

A man looking at his laptop and thinking.
Earnings Results

CSL shares push higher despite 'mixed result with headline misses'

There were positives and negatives in the company's first half performance.

Read more »

Scientists working in the laboratory and examining results.
Earnings Results

CSL share price on watch amid $2.1b half year profit and dividend hike

Let's see how this biotech giant performed during the first half of FY 2025.

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Guess which ASX 300 healthcare stock just rocketed 20% on BIG earnings growth

Investors are piling into the ASX 300 healthcare stock on Monday. But why?

Read more »

Health professional putting on gloves.
Earnings Results

Why this ASX 200 share is soaring in Monday's sinking market

The ASX 200 share is shrugging off the broader market fall today to rocket higher. But why?

Read more »

Three Archer Materials scientists wearing white coats and blue gloves dance together in their lab after making a discovery
Healthcare Shares

Why is the Sigma share price soaring 6%?

Sigma has upgraded its FY25 guidance ahead of the anticipated Chemist Warehouse merger completion.

Read more »

Stethoscope with a piggy bank and hundred dollar notes.
Healthcare Shares

Which ASX 200 healthcare share will pay the best dividend yield in 2025?

Earnings season is underway and dividend announcements are on investors' minds.

Read more »

A person is weighed down by a huge stack of coins, they have received a big dividend payout.
Dividend Investing

Looking to bag the record high ResMed dividend? You better hurry!

Unlike the majority of ASX 200 income stocks, ResMed pays dividends every quarter.

Read more »

Two lab workers fist pump each other.
Healthcare Shares

3 reasons to buy CSL shares today

Two investment experts expect a big turnaround for CSL shares in 2025.

Read more »